Michael Bader Selected Research

Serotonin (5 Hydroxytryptamine)

1/2022	Serotonin limits generation of chromaffin cells during adrenal organ development.
11/2021	Enduring Effects of Conditional Brain Serotonin Knockdown, Followed by Recovery, on Adult Rat Neurogenesis and Behavior.
1/2020	The Dual Role of Serotonin in Colorectal Cancer.
1/2020	Inhibition of serotonin synthesis: A novel therapeutic paradigm.
6/2019	ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models.
1/2019	Serotonin synthesis protects the mouse colonic crypt from DNA damage and colorectal tumorigenesis.
1/2019	Targeted Manipulation of Brain Serotonin: RNAi-Mediated Knockdown of Tryptophan Hydroxylase 2 in Rats.
12/2018	Brain serotonin critically contributes to the biological effects of electroconvulsive seizures.
1/2018	TPH2 Deficiency Influences Neuroplastic Mechanisms and Alters the Response to an Acute Stress in a Sex Specific Manner.
1/2018	Mast Cells and Serotonin Synthesis Modulate Chagas Disease in the Colon: Clinical and Experimental Evidence.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Bader Research Topics

Disease

42	Inflammation (Inflammations) 01/2022 - 12/2002
34	Hypertension (High Blood Pressure) 01/2022 - 06/2002
18	Cardiomegaly (Heart Hypertrophy) 01/2022 - 11/2002
15	Insulin Resistance 08/2020 - 02/2008
14	Fibrosis (Cirrhosis) 11/2020 - 08/2002
14	Obesity 05/2020 - 06/2008
13	Body Weight (Weight, Body) 12/2021 - 03/2005
11	Hypertrophy 12/2019 - 09/2002
10	Neoplasms (Cancer) 01/2022 - 01/2002
10	Ischemia 09/2008 - 01/2002
9	Myocardial Infarction 01/2017 - 04/2005
8	Pain (Aches) 01/2020 - 12/2002
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2009
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2010
7	Infarction (Infarctions) 01/2011 - 02/2002
6	Weight Gain 01/2021 - 06/2008
6	Hyperalgesia 01/2016 - 12/2002
5	Atherosclerosis 01/2021 - 10/2009
5	Stroke (Strokes) 01/2020 - 02/2002
5	Heart Failure 01/2020 - 10/2004
5	Edema (Dropsy) 11/2015 - 01/2003
4	AIDS-Related Complex (ARC) 04/2022 - 03/2006
4	Melanoma (Melanoma, Malignant) 10/2021 - 04/2005
4	Proteinuria 01/2021 - 01/2004
4	Atrophy 12/2020 - 04/2016
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 01/2018
4	Neuralgia (Stump Neuralgia) 01/2020 - 03/2005
4	Infections 01/2020 - 01/2003
4	Pre-Eclampsia (Preeclampsia) 12/2019 - 09/2014
4	Pulmonary Arterial Hypertension 01/2019 - 01/2007
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 04/2006
4	Diabetes Mellitus 01/2019 - 12/2004
4	Necrosis 01/2017 - 01/2002
4	Wounds and Injuries (Trauma) 05/2016 - 02/2004
4	Fatty Liver 12/2013 - 06/2003
4	Heart Diseases (Heart Disease) 02/2013 - 01/2003
4	Vascular Remodeling 08/2011 - 09/2002
4	Hypoxia (Hypoxemia) 06/2008 - 02/2002
3	Thrombosis (Thrombus) 01/2022 - 12/2003
3	Pneumonia (Pneumonitis) 01/2021 - 12/2008
3	Hypertensive Nephropathy 11/2020 - 02/2014
3	Non-alcoholic Fatty Liver Disease 05/2020 - 08/2007
3	Mental Disorders (Mental Disorder) 01/2020 - 11/2003
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 02/2008
3	Carcinoid Tumor (Carcinoid) 01/2020 - 06/2002
3	Glucose Intolerance 01/2020 - 02/2008
3	Weight Loss (Weight Reduction) 03/2017 - 02/2009
3	Endotoxemia 01/2016 - 06/2007

Drug/Important Bio-Agent (IBA)

45	KininsIBA 01/2022 - 01/2002
23	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 06/2002
22	Angiotensin IIIBA 11/2020 - 02/2002
21	ReninIBA 01/2022 - 02/2002
20	BradykininIBA 01/2019 - 08/2002
17	AngiotensinsIBA 01/2022 - 01/2004
17	angiotensin I (1-7)IBA 01/2021 - 05/2002
15	Proteins (Proteins, Gene)FDA Link 12/2020 - 09/2002
14	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2008
12	AngiotensinogenIBA 01/2020 - 02/2002
12	LeptinIBA 01/2020 - 02/2008
12	Peptides (Polypeptides)IBA 12/2018 - 11/2002
11	Messenger RNA (mRNA)IBA 01/2020 - 02/2002
8	LipidsIBA 10/2021 - 06/2003
8	Insulin (Novolin)FDA Link 01/2021 - 02/2008
8	LipopolysaccharidesIBA 12/2020 - 01/2003
8	2,5-dichloro-4-bromophenol (B 2)IBA 10/2011 - 12/2002
7	Streptozocin (Streptozotocin)FDA Link 01/2019 - 06/2002
7	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2017 - 06/2003
7	CytokinesIBA 12/2016 - 04/2004
7	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2016 - 01/2003
7	EnzymesIBA 01/2016 - 02/2002
7	Bradykinin Receptors (Bradykinin Receptor)IBA 09/2012 - 11/2006
6	Apolipoproteins E (ApoE)IBA 01/2022 - 10/2009
6	Tryptophan HydroxylaseIBA 02/2013 - 06/2002
5	Kallikreins (Kallikrein)IBA 01/2022 - 09/2002
5	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2020 - 02/2002
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 08/2002
5	salicylhydroxamic acid (SHAM)IBA 01/2020 - 04/2005
5	CollagenIBA 12/2019 - 11/2006
5	AldosteroneIBA 09/2014 - 03/2005
4	Biological ProductsIBA 01/2022 - 04/2004
4	SaltsIBA 01/2020 - 02/2002
4	AcidsIBA 07/2018 - 06/2003
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 03/2008
4	icatibantIBA 03/2013 - 05/2002
3	compound 21IBA 01/2022 - 03/2010
3	Blood Glucose (Blood Sugar)IBA 12/2021 - 03/2014
3	AlbuminsIBA 12/2021 - 11/2002
3	Prorenin ReceptorIBA 01/2021 - 12/2011
3	CholesterolIBA 01/2021 - 10/2009
3	Insulin ReceptorIBA 01/2021 - 01/2017
3	Angiotensin-Converting Enzyme 2IBA 12/2020 - 11/2008
3	CreatinineIBA 11/2020 - 01/2004
3	FR 173657IBA 01/2020 - 01/2009
3	Karyopherins (Importin)IBA 01/2020 - 01/2018
3	AVE 0991IBA 12/2019 - 11/2010
3	alamandineIBA 01/2019 - 04/2013
3	Pharmaceutical PreparationsIBA 07/2018 - 09/2014
3	ChemokinesIBA 12/2016 - 06/2009

Therapy/Procedure

9	Therapeutics 11/2020 - 01/2011
3	Intraperitoneal Injections 06/2018 - 02/2007